Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

BRAFV600E mutation is rare in clear cell ovarian carcinoma, but could potentially be identified with mutation specific immunohistochemistry

Dodds, Tristan1,2; D’Urso, Lisa1,2; Gill, Anthony J.1,2,3,4

Pathology - Journal of the RCPA: October 2015 - Volume 47 - Issue 6 - p 591–593
doi: 10.1097/PAT.0000000000000311
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website